NCT06983808 The PREBEAT Trial: Digital PREhaBilitation in thE Cardiac Surgical populATion
| NCT ID | NCT06983808 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Claire Hines |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-28 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-01-28 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomised controlled trial is to learn if a digital prehabilitation program is feasible in patients awaiting cardiac surgery. The main questions it aims to answer are: 1. Is the digital health program usable? 2. Is the digital health program acceptable? 3. Do patients adhere to the digital health program? Researchers will compare a group using the digital prehabilitation program with standard care to see if the program is feasible and explore any differences in health outcomes. Participants will * Use a digital health mobile phone application to guide you through exercise, nutrition and preparation for surgery. * Engage in telehealth consultations. * Complete questionnaires * Complete exercise testing
Eligibility Criteria
Inclusion Criteria: * 21 days+ prior to cardiac surgery * Able to provide consent, * Proficient in English to understand questionnaires, training instructions and outcome assessments. * Digitally literate to independently navigate a smart device and novel application. Exclusion Criteria: * severe or unstable neurological, cardiorespiratory, or musculoskeletal disease or mental illness that might compromise ability to perform exercise, * unstable psychiatric or cognitive disorders,
Contact & Investigator
Alistair Royse, MD - Cardiothoracic Surgeon
PRINCIPAL INVESTIGATOR
Melbourne Health
Frequently Asked Questions
Who can join the NCT06983808 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06983808 currently recruiting?
Yes, NCT06983808 is actively recruiting participants. Contact the research team at claire.hines@rmit.edu.au for enrollment information.
Where is the NCT06983808 trial being conducted?
This trial is being conducted at Melbourne, Australia.
Who is sponsoring the NCT06983808 clinical trial?
NCT06983808 is sponsored by Claire Hines. The principal investigator is Alistair Royse, MD - Cardiothoracic Surgeon at Melbourne Health. The trial plans to enroll 40 participants.